Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.
about
Integrating respiratory-gated PET-based target volume delineation in liver SBRT planning, a pilot study.The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases.Single-dose radiosurgical treatment for hepatic metastases--therapeutic outcome of 138 treated lesions from a single institution.The utility of positron emission tomography/computed tomography in target delineation for stereotactic body radiotherapy for liver metastasis from primary gastric cancer: an illustrative case report and literature review.Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute.4D-Listmode-PET-CT and 4D-CT for optimizing PTV margins in gastric lymphoma : Determination of intra- and interfractional gastric motion.Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors.The importance of surrounding tissues and window settings for contouring of moving targets.Influence of experience and qualification on PET-based target volume delineation. When there is no expert--ask your colleague.Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens.Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy.SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniques.Role of textural heterogeneity parameters in patient selection for 177Lu-PSMA therapy via response prediction
P2860
Q33729963-A4E89B10-6C95-4F4A-97A7-7D8FB1C6313BQ35593955-302E74A3-5437-4330-B887-A439A4D5D8E0Q37048588-51CA7049-1974-42D0-B14E-333BB58AC056Q39453628-9ABD17AB-55E1-4813-876A-56D8DA6D3FA5Q39520534-243AA9BE-2743-487B-A076-7FE78293FA41Q39978303-FB981639-A15C-4C8A-899B-17AE9D31C351Q45349782-248EA3D6-1CB8-48FD-AB3A-2185C73E82BBQ48514027-CE88FE20-2E30-48B6-9938-BA308AB4C0D4Q51103075-CD1C522C-C34B-49A9-BF70-39B4E96B0E6EQ51262657-D898099F-8EFC-40A7-825E-367703BA0CE6Q52983236-A3313DEA-48EB-471F-A8D3-AAFE0DB1D407Q53112046-5C1AE576-CE4B-4C8B-BC54-3969FCE676D5Q55220912-4EFBC47A-FA79-4C6E-BEB8-24917CDE699BQ57117099-13B4893F-138E-4F6F-8FC4-1015366DCD99
P2860
Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Respiratory gated [18F]FDG PET ...... treatment of liver metastases.
@en
Respiratory gated [18F]FDG PET ...... treatment of liver metastases.
@nl
type
label
Respiratory gated [18F]FDG PET ...... treatment of liver metastases.
@en
Respiratory gated [18F]FDG PET ...... treatment of liver metastases.
@nl
prefLabel
Respiratory gated [18F]FDG PET ...... treatment of liver metastases.
@en
Respiratory gated [18F]FDG PET ...... treatment of liver metastases.
@nl
P2093
P2860
P1476
Respiratory gated [18F]FDG PET ...... treatment of liver metastases
@en
P2093
N Andratschke
R A Bundschuh
S I Ziegler
S T Astner
P2860
P2888
P304
P356
10.1007/S00066-012-0094-3
P577
2012-03-24T00:00:00Z